Amarin Corp PLC (AMRN)
0.8566
0.00 (0.00%)
USD |
NASDAQ |
Dec 08, 16:00
0.85
-0.01
(-0.77%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 349.74M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -28.62% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.081 |
| Price to Book Value | 0.6323 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 97.26% |
Profile
| Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa. |
| URL | https://amarincorp.com |
| Investor Relations URL | https://amarincorp.com/global-login?next=/investor-relations |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Equity Style | N/A |
| Next Earnings Release | Mar. 01, 2024 (est.) |
| Last Earnings Release | Nov. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa. |
| URL | https://amarincorp.com |
| Investor Relations URL | https://amarincorp.com/global-login?next=/investor-relations |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Equity Style | N/A |
| Next Earnings Release | Mar. 01, 2024 (est.) |
| Last Earnings Release | Nov. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |